169 related articles for article (PubMed ID: 2473217)
1. Semliki Forest virus E2 envelope epitopes induce a nonneutralizing humoral response which protects mice against lethal challenge.
Grosfeld H; Velan B; Leitner M; Cohen S; Lustig S; Lachmi BE; Shafferman A
J Virol; 1989 Aug; 63(8):3416-22. PubMed ID: 2473217
[TBL] [Abstract][Full Text] [Related]
2. Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity.
Grosfeld H; Lustig S; Gozes Y; Velan B; Cohen S; Leitner M; Lachmi B; Katz D; Olshevski U; Shafferman A
J Virol; 1992 Feb; 66(2):1084-90. PubMed ID: 1309890
[TBL] [Abstract][Full Text] [Related]
3. Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus.
Grosfeld H; Velan B; Leitner M; Lustig S; Lachi BE; Cohen S; Shafferman A
Vaccine; 1991 Jun; 9(6):451-6. PubMed ID: 1716035
[TBL] [Abstract][Full Text] [Related]
4. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.
Snijders A; Benaissa-Trouw BJ; Oosterlaken TA; Puijk WC; Posthumus WP; Meloen RH; Boere WA; Oosting JD; Kraaijeveld CA; Snippe H
J Gen Virol; 1991 Mar; 72 ( Pt 3)():557-65. PubMed ID: 1706409
[TBL] [Abstract][Full Text] [Related]
5. A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production.
Snijders A; Benaissa-Trouw BJ; Visser-Vernooy HJ; Fernandez I; Snippe H; Kraaijeveld CA
Immunology; 1992 Nov; 77(3):322-9. PubMed ID: 1282493
[TBL] [Abstract][Full Text] [Related]
6. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
Fernández IM; Snijders A; Benaissa-Trouw BJ; Harmsen M; Snippe H; Kraaijeveld CA
J Virol; 1993 Oct; 67(10):5843-8. PubMed ID: 7690411
[TBL] [Abstract][Full Text] [Related]
7. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
[TBL] [Abstract][Full Text] [Related]
8. Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.
Ariel N; Lehrer S; Elhanaty E; Sabo T; Brodt P; Lachmi B; Katz D; Levin R; Grosfeld H; Velan B
Arch Virol; 1990; 113(1-2):99-106. PubMed ID: 1696808
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes.
Snijders A; Benaissa-Trouw BJ; Snippe H; Kraaijeveld CA
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2267-72. PubMed ID: 1383405
[TBL] [Abstract][Full Text] [Related]
10. Studies on linear epitopes of Semliki Forest virus in protection studies against lethal challenge virus infection.
Truyen U; Kaaden OR
Zentralbl Veterinarmed B; 1991 Aug; 38(6):463-7. PubMed ID: 1719714
[TBL] [Abstract][Full Text] [Related]
11. Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines.
Fernández IM; Harmsen M; Benaissa-Trouw BJ; Stuij I; Puyk W; Meloen RH; Snippe H; Kraaijeveld CA
Vaccine; 1998 Oct; 16(16):1531-6. PubMed ID: 9711800
[TBL] [Abstract][Full Text] [Related]
12. A shared idiotope among antibodies against Semliki Forest virus.
Fernández IM; Ovaa W; Harmsen M; Benaissa-Trouw BJ; Bos NA; Kraaijeveld CA; Snippe H
Viral Immunol; 1994; 7(2):71-80. PubMed ID: 7531444
[TBL] [Abstract][Full Text] [Related]
13. The significance of carbohydrate trimming for the antigenicity of the Semliki Forest virus glycoprotein E2.
Kaluza G; Repges S; McDowell W
Virology; 1990 Jun; 176(2):369-78. PubMed ID: 1693245
[TBL] [Abstract][Full Text] [Related]
14. Identification of a DTH-inducing T-cell epitope on the E2 membrane protein of Semliki Forest virus.
Snijders A; Benaissa-Trouw BJ; Oosting JD; Snippe H; Kraaijeveld CA
Cell Immunol; 1989 Oct; 123(1):23-35. PubMed ID: 2476243
[TBL] [Abstract][Full Text] [Related]
15. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.
Boere WA; Harmsen T; Vinjé J; Benaissa-Trouw BJ; Kraaijeveld CA; Snippe H
J Virol; 1984 Nov; 52(2):575-82. PubMed ID: 6208379
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
J Virol; 1985 May; 54(2):546-51. PubMed ID: 2985817
[TBL] [Abstract][Full Text] [Related]
17. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
Boere WA; Kraaijeveld CA; Snippe H
Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
[No Abstract] [Full Text] [Related]
18. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
Oosterlaken TA; Harmsen M; Jhagjhoor-Singh SS; Ekstijn GL; Kraaijeveld CA; Snippe H
J Virol; 1991 Jan; 65(1):98-102. PubMed ID: 1845911
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
Barrett AD; Dimmock NJ
J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
Balcarova J; Helenius A; Simons K
J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
